tiprankstipranks
GlaxoSmithKline Pharmaceuticals Limited (IN:GLAXO)
:GLAXO
India Market
Want to see IN:GLAXO full AI Analyst Report?

GlaxoSmithKline Pharmaceuticals Limited (GLAXO) Ratios

7 Followers

GlaxoSmithKline Pharmaceuticals Limited Ratios

IN:GLAXO's free cash flow for Q2 2026 was ₹0.48. For the 2026 fiscal year, IN:GLAXO's free cash flow was decreased by ₹ and operating cash flow was ₹0.36. See a summary of the company’s cash flow.
Ratios
TTM
Mar 26Mar 25Mar 24Mar 23
Liquidity Ratios
Current Ratio
2.03 2.03 1.79 1.84 1.88
Quick Ratio
1.77 1.77 1.54 1.49 1.53
Cash Ratio
0.78 0.78 0.28 0.04 0.03
Solvency Ratio
0.54 0.54 0.46 0.35 0.41
Operating Cash Flow Ratio
0.10 0.57 0.68 0.38 0.37
Short-Term Operating Cash Flow Coverage
0.00 0.00 0.00 47.72 11.53
Net Current Asset Value
₹ 15.50B₹ 15.50B₹ 12.53B₹ 10.19B₹ 9.09B
Leverage Ratios
Debt-to-Assets Ratio
<0.01 <0.01 <0.01 <0.01 <0.01
Debt-to-Equity Ratio
0.01 0.01 <0.01 0.01 <0.01
Debt-to-Capital Ratio
0.01 0.01 <0.01 0.01 <0.01
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.91 1.91 2.11 2.00 1.91
Debt Service Coverage Ratio
391.65 344.02 844.19 46.75 12.78
Interest Coverage Ratio
455.22 455.22 944.92 756.21 684.80
Debt to Market Cap
0.00 0.00 0.00 <0.01 <0.01
Interest Debt Per Share
2.12 2.12 0.66 1.21 1.02
Net Debt to EBITDA
-0.94 -1.04 -0.40 -0.05 -0.02
Profitability Margins
Gross Profit Margin
55.92%47.02%60.47%60.76%59.89%
EBIT Margin
35.92%32.52%33.85%24.29%23.02%
EBITDA Margin
37.66%34.26%35.64%25.50%24.25%
Operating Profit Margin
32.52%32.52%29.91%39.38%38.12%
Pretax Profit Margin
36.79%36.79%33.81%23.63%25.72%
Net Profit Margin
27.11%27.11%24.89%17.08%18.78%
Continuous Operations Profit Margin
27.11%27.11%24.89%17.08%18.69%
Net Income Per EBT
73.68%73.68%73.62%72.28%73.01%
EBT Per EBIT
113.14%113.14%113.06%60.00%67.48%
Return on Assets (ROA)
23.96%23.96%22.58%16.59%18.36%
Return on Equity (ROE)
52.60%45.69%47.54%33.19%35.07%
Return on Capital Employed (ROCE)
48.84%48.84%50.59%66.95%61.97%
Return on Invested Capital (ROIC)
35.76%35.76%37.12%47.82%43.83%
Return on Tangible Assets
24.00%24.00%22.65%16.70%18.55%
Earnings Yield
2.65%2.68%1.96%1.75%2.71%
Efficiency Ratios
Receivables Turnover
13.99 13.99 10.33 9.87 9.85
Payables Turnover
2.95 3.55 2.08 2.17 2.09
Inventory Turnover
3.68 4.43 3.06 2.58 2.84
Fixed Asset Turnover
12.47 12.47 13.13 11.11 10.32
Asset Turnover
0.88 0.88 0.91 0.97 0.98
Working Capital Turnover Ratio
2.45 2.29 2.68 2.83 2.05
Cash Conversion Cycle
1.67 5.77 -20.78 9.95 -9.26
Days of Sales Outstanding
26.08 26.08 35.35 36.98 37.04
Days of Inventory Outstanding
99.14 82.48 119.37 141.41 128.74
Days of Payables Outstanding
123.56 102.79 175.50 168.44 175.04
Operating Cycle
125.23 108.57 154.72 178.39 165.78
Cash Flow Ratios
Operating Cash Flow Per Share
10.84 60.35 76.14 34.36 28.44
Free Cash Flow Per Share
9.84 57.09 74.78 32.51 25.85
CapEx Per Share
1.01 3.26 1.36 1.84 2.59
Free Cash Flow to Operating Cash Flow
0.91 0.95 0.98 0.95 0.91
Dividend Paid and CapEx Coverage Ratio
0.25 1.33 1.67 1.02 0.31
Capital Expenditure Coverage Ratio
10.78 18.50 56.03 18.64 11.00
Operating Cash Flow Coverage Ratio
5.52 30.73 129.64 31.18 31.16
Operating Cash Flow to Sales Ratio
0.05 0.27 0.35 0.17 0.15
Free Cash Flow Yield
0.43%2.50%2.67%1.64%1.95%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
37.73 37.33 51.09 57.04 36.93
Price-to-Sales (P/S) Ratio
10.23 10.12 12.72 9.74 6.94
Price-to-Book (P/B) Ratio
17.24 17.06 24.29 18.93 12.95
Price-to-Free Cash Flow (P/FCF) Ratio
234.43 39.99 37.41 61.09 51.24
Price-to-Operating Cash Flow Ratio
212.72 37.83 36.74 57.81 46.58
Price-to-Earnings Growth (PEG) Ratio
3.23 3.20 0.89 -19.67 0.54
Price-to-Fair Value
17.24 17.06 24.29 18.93 12.95
Enterprise Value Multiple
26.21 28.51 35.29 38.16 28.58
Enterprise Value
377.23B 373.20B 468.60B 336.04B 225.35B
EV to EBITDA
26.21 28.51 35.29 38.16 28.58
EV to Sales
9.87 9.77 12.58 9.73 6.93
EV to Free Cash Flow
226.29 38.59 36.99 61.01 51.19
EV to Operating Cash Flow
205.30 36.50 36.33 57.74 46.54
Tangible Book Value Per Share
133.83 133.84 114.40 103.54 100.27
Shareholders’ Equity Per Share
133.83 133.84 115.19 104.93 102.27
Tax and Other Ratios
Effective Tax Rate
0.26 0.26 0.26 0.28 0.27
Revenue Per Share
225.56 225.58 219.95 203.87 190.99
Net Income Per Share
61.15 61.15 54.76 34.83 35.87
Tax Burden
0.74 0.74 0.74 0.72 0.73
Interest Burden
1.02 1.13 1.00 0.97 1.12
Research & Development to Revenue
0.00 0.00 0.00 <0.01 <0.01
SG&A to Revenue
0.11 0.15 0.19 0.18 0.18
Stock-Based Compensation to Revenue
0.00 0.00 0.00 <0.01 <0.01
Income Quality
0.16 0.99 1.39 0.99 0.58
Currency in INR